Generics
Apotex Corporation introduces authorised generic version of Combigan Ophthalmic Solution in US
20 January 2022 -

United States-based Apotex Corporation announced on Wednesday that it has introduced the authorised generic version of Combigan (Brimonidine Timolol OPSO 0.2%/0.5%) in the United States.

Brimonidine Timolol is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Peter Hardwick, Apotex Corp president, said, 'We are proud to provide American patients with cost savings by bringing the first generic version of Combigan to patients, allowing for a low-cost, high-quality solution.'

Login
Username:

Password: